Brand Name(s): Asacol; Pentasa; Rowasa;
Mesasal; Salofalk
CAS nš: 89-57-6
(me SAL a meen)
What is Mesalamine?
Mesalamine (mesalazine) is an anti-inflammatory medication used to treat inflammation of the digestive tract (such as Crohn's disease) and mild to moderate ulcerative colitis, proctitis, and proctosigmoiditis. It also helps prevent symptoms caused by the above from recurring.
Mesalazine is a bowel-specific aminosalicylate drug that is metabolized in the gut and has its predominant actions there, thereby having fewer systemic side effects. It works by affecting a substance in the body that causes inflammation, tissue damage, and diarrhea.
Latest News
First and Only Once-Daily Mesalamine for Active, Mild to Moderate Ulcerative Colitis Now Available in Canada
Shire plc, the global specialty biopharmaceutical company, today announced the availability in...
[more]Survey Reveals Differing Physician, Patient Perceptions
Nearly three out of four patients with ulcerative colitis (UC) consider feeling unwell to be a...
[more]FDA Approves Lialda First Once-daily Mesalamine for UC
FDA Approves LIALDA (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active,...
[more]Colitis patients need better immunization: report
People with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative...
[more]Oral Mesalamine Prodrug Approved for Active Ulcerative Colitis
Salix Pharmaceuticals has received approval to market balsalazide disodium (Colazal) oral capsules...
[more]